Sign Up to like & get
recommendations!
1
Published in 2022 at "AAPS PharmSciTech"
DOI: 10.1208/s12249-022-02406-6
Abstract: Sorafenib tosylate (SFNT) is the first-line drug for hepatocellular carcinoma. It exhibits poor solubility leading to low oral bioavailability subsequently requiring intake of large quantities of drug to exhibit desired efficacy. The present investigation was…
read more here.
Keywords:
ternary inclusion;
inclusion complex;
sorafenib tosylate;
inclusion ... See more keywords